These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7858972)

  • 1. Polyclonal antibodies and catalysis.
    Stephens DB; Wilmore BH; Iverson BL
    Bioorg Med Chem; 1994 Jul; 2(7):653-8. PubMed ID: 7858972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal antibody catalytic variability.
    Stephens DB; Thomas RE; Stanton JF; Iverson BL
    Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):127-34. PubMed ID: 9576860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic polyclonal antibodies.
    Stephens DB; Iverson BL
    Biochem Biophys Res Commun; 1993 May; 192(3):1439-44. PubMed ID: 8507208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens.
    Odenbaugh AL; Helms ED; Iverson BL
    Bioorg Med Chem; 2000 Feb; 8(2):413-26. PubMed ID: 10722164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polyclonal antibody preparation with Michaelian catalytic properties.
    Gallacher G; Jackson CS; Searcey M; Badman GT; Goel R; Topham CM; Mellor GW; Brocklehurst K
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):871-81. PubMed ID: 1953683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of catalytic antibody repertoire in autoimmune mice.
    Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):213-33. PubMed ID: 12379363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common ancestry for multiple catalytic antibodies generated against a single transition-state analog.
    Miyashita H; Hara T; Tanimura R; Tanaka F; Kikuchi M; Fujii I
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6045-9. PubMed ID: 8016113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity?
    Tawfik DS; Chap R; Green BS; Sela M; Eshhar Z
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2145-9. PubMed ID: 7892238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic antibody activity elicited by active immunisation. Evidence for natural variation involving preferential stabilization of the transition state.
    Gallacher G; Jackson CS; Searcey M; Goel R; Mellor GW; Smith CZ; Brocklehurst K
    Eur J Biochem; 1993 May; 214(1):197-207. PubMed ID: 8508792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to a hapten of fluorescein isothiocyanate in a single mouse analyzed by two-dimensional affinity electrophoresis.
    Nakamura K; Mimura Y; Takeo K
    Electrophoresis; 1993; 14(1-2):81-7. PubMed ID: 8462521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the anti-idiotypic responses generated by antibodies to a protein and a hapten: a common interspecies idiotype on antibodies against human albumin induces an idiotypic network in rabbits.
    Comacchio RM; Bradley J; Hohmann AW
    Immunol Cell Biol; 1996 Feb; 74(1):72-80. PubMed ID: 8934657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of polyclonal and monoclonal antibodies against the insecticide DDT.
    Bürgisser D; Frey S; Gutte B; Klauser S
    Biochem Biophys Res Commun; 1990 Feb; 166(3):1228-36. PubMed ID: 2306239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of passively administered isologous anti-idiotypes directed against anti-carrier (ovalbumin) antibodies on the anti-hapten IgE and IgG antibody responses in BALB/c mice.
    Blaser K; Nakagawa T; De Weck AL
    Immunology; 1983 Mar; 48(3):423-31. PubMed ID: 6600704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Catalytic antibodies: generation of a new class of protein catalysts exploiting the immune system].
    Fujii I
    Yakugaku Zasshi; 1996 Aug; 116(8):606-21. PubMed ID: 8831262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed appearance of the catalytic activity by immunization of a rabbit compared with the hapten binding.
    Suzuki H; Sasaki K; Mukouyama EB; Kawamura-Konishi Y; Wada Y; Ono M
    Biochem Mol Biol Int; 1994 Aug; 34(1):27-35. PubMed ID: 7849622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An active immunization approach to generate protective catalytic antibodies.
    Wang J; Han Y; Wilkinson MF
    Biochem J; 2001 Nov; 360(Pt 1):151-7. PubMed ID: 11696002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A general kinetic approach to investigation of active-site availability in macromolecular catalysts.
    Resmini M; Gul S; Carter S; Sonkaria S; Topham CM; Gallacher G; Brocklehurst K
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):117-25. PubMed ID: 10657247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis.
    Longenecker BM; Reddish M; Koganty R; MacLean GD
    Adv Exp Med Biol; 1994; 353():105-24. PubMed ID: 7527178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence.
    Laudenbach M; Tucker AM; Runyon SP; Carroll FI; Pravetoni M
    Vaccine; 2015 Nov; 33(46):6332-9. PubMed ID: 26409811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.